Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_assertion type Assertion NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_head.
- NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_provenance.
- NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_assertion evidence source_evidence_literature NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_provenance.
- NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_assertion SIO_000772 18676740 NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_provenance.
- NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_assertion wasDerivedFrom befree-2016 NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_provenance.
- NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_assertion wasGeneratedBy ECO_0000203 NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_provenance.